ArticleAesthetic surgery journal. Open forum2026
Use of VISIA-CR Generation 5 in Aesthetic Skin Assessment: A Single-Case Review.
Article in Aesthetic surgery journal. Open forum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Traditional evaluations of nonsurgical aesthetic treatments often rely on clinical photography and patient-reported outcomes, which are subjective and may overlook subtle or subsurface changes. Advanced imaging technologies, such as the VISIA-CR system, have increased objectivity; however, earlier generations provided limited parameters and lacked integrated analytics. The aim of this review was to illustrate the enhanced capabilities of the VISIA-CR Generation 5 system (VISIA-CR 5) and explore its clinical relevance through a single-case example. A 49-year-old female with Fitzpatrick skin phototype III underwent a combined treatment with intense pulsed light, a fractionated 1927 nm laser, and a dual-wavelength 1470/2940 nm laser. Standardized VISIA-CR 5 imaging was performed at baseline and 3 months. The system captured multispectral images and quantified 8 skin features (visible spots, brown spots, red spots, ultraviolet (UV) spots, texture, pores, porphyrins, and wrinkles) using expanded multiparameter analytics. The VISIA-CR 5 provided multidimensional assessment beyond conventional visual evaluation by quantifying feature intensity, background skin tone, and relative contrast. Although the mean intensity of visible, brown, and UV spots appeared darker at 3 months, contrast-based analysis indicated improved skin tone uniformity. The system also detected reduced fractional area alongside increased count for visible and UV spots, suggesting fragmentation of larger spots rather than proliferation, a level of detail unattainable with traditional methods. This case demonstrates that the VISIA-CR 5 can provide detailed imaging and integrated analytics that support comprehensive, objective evaluation of aesthetic treatment outcomes. Its expanded parameters facilitate detection of subtle, clinically relevant changes and highlight its potential utility in clinical research and practice.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.